ATE48617T1 - Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel. - Google Patents

Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel.

Info

Publication number
ATE48617T1
ATE48617T1 AT85902248T AT85902248T ATE48617T1 AT E48617 T1 ATE48617 T1 AT E48617T1 AT 85902248 T AT85902248 T AT 85902248T AT 85902248 T AT85902248 T AT 85902248T AT E48617 T1 ATE48617 T1 AT E48617T1
Authority
AT
Austria
Prior art keywords
cells
new
tumour
subunit
patient
Prior art date
Application number
AT85902248T
Other languages
English (en)
Inventor
Janet H Ransom
Richard P Mccabe
Martin V Haspel
Nicholas Pomato
Original Assignee
Litton Bionetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Litton Bionetics Inc filed Critical Litton Bionetics Inc
Application granted granted Critical
Publication of ATE48617T1 publication Critical patent/ATE48617T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT85902248T 1984-04-13 1985-04-11 Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel. ATE48617T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60030384A 1984-04-13 1984-04-13
EP85902248A EP0179127B1 (de) 1984-04-13 1985-04-11 Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel
PCT/US1985/000626 WO1985004662A1 (en) 1984-04-13 1985-04-11 Leukoregulin, an antitumor lymphokine, and its therapeutic uses

Publications (1)

Publication Number Publication Date
ATE48617T1 true ATE48617T1 (de) 1989-12-15

Family

ID=24403068

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85902248T ATE48617T1 (de) 1984-04-13 1985-04-11 Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel.

Country Status (9)

Country Link
EP (1) EP0179127B1 (de)
JP (2) JP2562014B2 (de)
AT (1) ATE48617T1 (de)
AU (2) AU592529B2 (de)
DE (1) DE3574710D1 (de)
DK (2) DK170781B1 (de)
FI (1) FI85867C (de)
NO (1) NO170423C (de)
WO (1) WO1985004662A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE48617T1 (de) * 1984-04-13 1989-12-15 Litton Bionetics Inc Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel.
US5683688A (en) * 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
US6087166A (en) 1997-07-03 2000-07-11 Basf Aktiengesellschaft Transcriptional activators with graded transactivation potential
EP2026776A2 (de) 2006-05-15 2009-02-25 Paratek Pharmaceuticals, Inc. Verfahren zur regelung der genexpression oder genprodukte mithilfe von substituierten tetracyclinverbindungen
EP2710130B1 (de) 2011-05-19 2022-06-29 Fundación Pública Andaluza Progreso Y Salud Effizient induzierbare lentivirale tet-on-vektor system mit zwei-promotoren

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394448A (en) * 1978-02-24 1983-07-19 Szoka Jr Francis C Method of inserting DNA into living cells
US4403035A (en) * 1981-06-19 1983-09-06 Regents Of The University Of Minnesota In vitro DNA-Protein viral assembly and gene cloning system
DE3138230A1 (de) * 1981-09-25 1983-04-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur gewinnung von makrophagen- aktivierungsfaktor (maf)
JPS6011889B2 (ja) * 1981-10-28 1985-03-28 電気化学工業株式会社 継代可能なリンホカイン産生ヒトｔ細胞融合株及びその取得方法
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
ZA834976B (en) * 1982-07-30 1984-08-29 Genentech Inc Human lymphotoxin
EP0135797A3 (de) * 1983-08-30 1987-11-11 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung von Lymphotoxin und von Lymphotoxin-mRNA
ATE48617T1 (de) * 1984-04-13 1989-12-15 Litton Bionetics Inc Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel.

Also Published As

Publication number Publication date
AU4234185A (en) 1985-11-01
AU592529B2 (en) 1990-01-18
DK170423B1 (da) 1995-08-28
DK98692A (da) 1992-08-04
EP0179127A1 (de) 1986-04-30
DK170781B1 (da) 1996-01-15
FI85867B (fi) 1992-02-28
AU641386B2 (en) 1993-09-23
DE3574710D1 (de) 1990-01-18
NO170423C (no) 1992-10-14
JP2562014B2 (ja) 1996-12-11
FI854803A (fi) 1985-12-04
AU5365390A (en) 1990-09-20
JPH06253832A (ja) 1994-09-13
FI854803A0 (fi) 1985-12-04
NO170423B (no) 1992-07-06
FI85867C (fi) 1992-06-10
NO854994L (no) 1985-12-12
EP0179127B1 (de) 1989-12-13
JPS61501853A (ja) 1986-08-28
DK562285A (da) 1985-12-04
DK562285D0 (da) 1985-12-04
WO1985004662A1 (en) 1985-10-24
JP2564245B2 (ja) 1996-12-18
DK98692D0 (da) 1992-08-04
EP0179127A4 (de) 1986-08-21

Similar Documents

Publication Publication Date Title
DK0702563T3 (da) Sammensætninger og fremgangsmåder til behandling af cancer og hyperproliferative sygdomme
HUT70471A (en) Antitumor imunoconjugates, method for producing them, and pharmaceutical compositions containing the conjugates
CA2202028A1 (en) Tie-2 ligands, methods of making and uses thereof
WO1996011269B1 (en) Tie-2 ligands, methods of making and uses thereof
Kudlow et al. Inability of anti-epidermal growth factor receptor monoclonal antibody to block “autocrine” growth stimulation in transforming growth factor-secreting melanoma cells.
ATE48617T1 (de) Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel.
Tagliaferri et al. Two classes of cAMP analogs synergistically inhibit p21 ras protein synthesis and phenotypic transformation of NIH3T3 cells transfected with Ha-MuSV DNA
CN108463730A (zh) 包含重组人促甲状腺激素的组合物以及生产重组人促甲状腺激素的方法
AU2001220255A1 (en) Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferationof cancer cell using the expression vector
Karpas A humoral cytotoxic substance produced by a human killer cell line
SU1173990A1 (ru) Способ определени активности процесса костеобразовани
MX9707617A (es) Factor de crecimiento de criptina humano.
JPH03505575A (ja) 幹細胞阻害剤
Greenberger et al. Biochemical Purification of a CSF-1 like Molecule Released during Malignant Transformation of IL-3 Dependent Hematopoietic Progenitor cell lines Cocultivated with Gamma Irradiated Clonal Marrow Stromal cell lines
CN100425699C (zh) scFvC6.5-TNF-α融合基因和蛋白及制备
LINES et al. Department Of Radiation Oncology, University Of Massachusetts Medical Center, Worcester, MA 01655 Cocultivation of IL-3 dependent hematopoietic progenitor cell line FDC-P1JL26 with 5000 cGy irradiated clonal bone marrow
CN1348005A (zh) 重构、靶向半胱天冬酶基因的制备及其用途
CN106349383A (zh) 人sfrp1变体及其应用
CN106349376A (zh) 人sfrp1变体及其应用
CN106349382A (zh) 人sfrp1变体及其应用
CN106349381A (zh) 人sfrp1变体及其应用
CN106349375A (zh) 人sfrp1变体及其应用
CN106349374A (zh) 人sfrp1变体及其应用
CN106336454A (zh) 人sfrp1变体及其应用
CN106349370A (zh) 人sfrp1变体及其应用

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee